Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 19Unknown 7Terminated 7Recruiting 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Uveal Melanoma 1Neoplasms 1Female Breast Cancer 1Fatigue 1Depression 1Anxiety Disorders 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Melatonin × Clear all
NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
188 enrolled

Anxiety Disorders, Depression, Fatigue, Neoplasms

NCT05502900 2025-05-15

AMUM

St. Erik Eye Hospital

Phase 3 Recruiting
100 enrolled
Dermatologic

Uveal Melanoma

NCT06696378 2024-11-20

MEXBSO

University of Valladolid

Phase NA Recruiting
120 enrolled
Breast

Female Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡